| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |